cosmetic MD

page-feature

Stacks Image 21
For many people, there are stubborn areas of fat that refuses to shift, despite diet and exercise. These include the under chin area (double chin), the lower abdomen (love handles), thighs, and the buttocks. These persistent areas of fat are common among all kinds of people, even those that are fit and at their ideal weight.

In their
Consumer Survey in 2016, the American Society for Dermatologic Surgery, found that 73% of patients surveyed listed "excess fat under the chin or neck" as one of their top concerns. A similar Australian survey in 2016 found 59% of females and 41% of males were concerned about fullness under the chin.

For the double chin, the appearance is not simply due to body weight but can develop as a result of ageing or from genetic factors. This makes it difficult to fix with just diet and exercise.

Until recently, the main treatment option for the double chin and other stubborn areas of fat was surgical liposuction, which has its own risks and benefits.

cosmetic MD
can now offer a non-surgical option in the form of fat-dissolving injections to reduce double chins. These injections are widely known as Kybella (which is the American trade name).*

Kybella is given through a series of quick, comfortable injections. In just a few months, you can appreciate the difference this product makes as your double chin begins to diminish and you notice a more defined, sleeker chin and neck.

Please call or email us to book a consultation with our doctor. Note that all patients must have a medical consultation first to determine your suitability for the treatment. In some cases, we may recommend an alternative treatment for your concerns with the under chin area.

Stacks Image 33



How does Kybella work?


The active ingredient in Kybella is a naturally occurring substance made in the liver. It normally helps in digesting dietary fat. When injected into areas of unwanted fat, Kybella helps the body to metabolise and filter away this fat. It has been studied over 10 years and has been safely used in over 2600 patients in worldwide clinical trials. More recently, it has gained FDA, Health Canada and TGA approval for treatment of submental fat (double chin).


What can I expect during the treatment?

During each treatment session, the skin is first cleansed and numbed to prepare it for injections. The injector then administers several quick injections beneath your chin. Treatment sessions usually take 30 minutes or less. After your treatment, you may return to your normal activities immediately.

Although you may experience some bleeding, swelling, bruising, tenderness or numbness at or near the treatment area, these side effects are typically short-lived and mild.

How many sessions do I need?

Kybella is administered as a series of sessions spaced 6 to 8 weeks apart for the best results.

Most patients will need between 2 to 4 treatments, depending on how much fat is in the under chin area to start with.

Over time, you’ll notice your double chin gradually receding, revealing a slimmer, natural-looking neckline.

The final results are expected to last at least 5 years.

Who should not receive Kybella?

Kybella has not been approved for patients under 18 years of age.

You should also not receive Kybella if you have an infection in the treatment area, if you have had or plan to have surgery on your face, neck, or chin; have had cosmetic treatments on your face, neck, or chin; have had or have medical conditions in or near the neck area; have had or have trouble swallowing; have bleeding problems; are pregnant or plan to become pregnant (it is not known if Kybella can harm your unborn baby); or are breastfeeding or plan to breastfeed (it is not known if Kybella passes into your breast milk.

What are the possible side effects of Kybella?

The most common side effects include swelling, bruising, pain, numbness, redness, and areas of hardness in the treatment area. These are all temporary and most usually resolve in a few days.


* - Because it is a prescription only medicine in Australia, we cannot name the Australian drug name

In The News

Cosmopolitan, 13 April 2016

Science Daily, 4 August 2015

Fusion, 5 April 2015

ABC News, 14 March 2015